Business

Molina Healthcare Announces Closing of Offering of $850 Million of 6.500% Senior Notes Due 2031

LONG BEACH, Calif., November 20, 2025--Molina Healthcare, Inc. (NYSE: MOH) (the "Company") today announced the closing of its previously announced offering of $850 million aggregate principal amount of 6.500% senior notes due 2031 (the "Notes") sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons outside the United States in re

articleMolina Healthcare IncNovember 20, 20253/company/molina-healthcare-inc/news/molina-healthcare-announces-closing-offering-211500675
Molina Healthcare Announces Closing of Offering of $850 Million of 6.500% Senior Notes Due 2031

About this update from Molina Healthcare Inc

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/6bff20268a61f701eea4d2fe475b776b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xRJqE4F5yxn9RDIYB2qOEA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/6bff20268a61f701eea4d2fe475b776b","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/SnQgrSfx1ECYRoQc9y_SIA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/6bff20268a61f701eea4d2fe475b776b","width":1024,"height":512}},"lazy":false},{"type":"text","content":"LONG BEACH, Calif., November 20, 2025--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the "Company") today announced the closing of its previously announced offering of $850 million aggregate principal amount of 6.500% senior notes due 2031 (the "Notes") sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act.","length":605,"tagName":"p"},{"type":"text","content":"The Notes bear interest at a rate of 6.500% per annum. Interest on the Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing August 15, 2026 and accrues from November 20, 2025. The Notes will mature on February 15, 2031.","length":262,"tagName":"p"},{"type":"text","content":"After deducting fees and expenses payable by the Company, the net proceeds from the issuance and sale of the Notes were approximately $838 million (the "Net Proceeds"). The Company intends to use the Net Proceeds for general corporate purposes, including to repay the Company’s outstanding delayed draw term loans under its existing credit agreement.","length":360,"tagName":"p"},{"type":"text","content":"The Notes have not been and will not be registered under the Securities Act or any state securities laws and may not be offered or sold within the United States or to, or for the benefit of, a U.S. person (as defined in Regulation ...

More updates from Molina Healthcare Inc

Molina HealthcareThe CompanySecurities Act of 1933forward-looking statementsCompanynet proceeds